Yes, especially if you were prediabetic before starting, or if urination is excessive (more than 3 liters daily or urgent every hour)
S., Edwards, W
What Clinicians Should Expect Next May 11, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,382 views The rapid rise of GLP-1 receptor agonists has transformed diabetes treatment and obesity management over the past decade
However, the increase of the anticoagulant effectors is inconsistent with a prothrombotic environment
Benefits of Injectable Administration Systemic Effects: Provides whole-body benefits, including potential hair growth stimulation and systemic tissue repair
This may occur when the body regurgitates material from the gastrointestinal tract